Maternal Health
Michael Warren, M.D., associate administrator for the Health Resources and Services Administration’s Maternal and Child Health Bureau, discusses why the agency launched the hotline last Mother’s Day and how it provides confidential support to pregnant and new mothers who call or text 1-833-TLC-MAMA.
AHA and its Institute for Diversity and Health Equity at the 38th National Association of Health Services Executives (N.A.H.S.E.) Annual Education Conference in Atlanta hosted Understanding Bias in Black Maternal Health, which included a screening of “Toxic: A Black Woman’s Story.”
The Centers for Medicare & Medicaid Services Nov. 8 began displaying its “birthing friendly” hospital designation on Medicare’s Care Compare website and through a new mapping tool.
Two maternal health experts explore common disparities and systemic barriers Indigenous people experience in pregnancy and postpartum, and ways hospitals and health care organizations can combat these challenges to provide culturally-focused care.
In this conversation, Tina Pattara-Lau, M.D., maternal and child health consultant with the Indian Health Service Office of Clinical and Preventive Services, and Johnna Nynas, M.D. obstetrics and gynecology specialist at Sanford Bemidji Medical Center, explore common disparities and systemic…
Over 3,700 babies were born with syphilis in 2022, 32% more than in 2021 and 10 times more than in 2012, the Centers for Disease Control and Prevention reported Nov. 7.
Children under age 12 should receive a 0.25 milliliter dose of the 2023-24 Moderna COVID-19 vaccine, not the full vial for that age group, the Food and Drug Administration reminded health care providers recently.
The three-part Beyond Birth podcast series explores how hospitals and health systems can support the social and emotional needs of pregnant people and new parents.
American health care has come a long way over the years, but there is at least one glaring exception — maternal health.
The Centers for Disease Control and Prevention Oct. 23 released interim guidance for clinicians with limited access to the monoclonal antibody nirsevimab, recently approved to prevent respiratory syncytial virus in children aged 2 and under.